The search for biomarkers to detect early cases of cancer, track its progression, and monitor therapeutic success is a decades-old odyssey. An article recently published in the journal Trends in Cancer details the advances and hurdles in the development of cancer biomarkers. Andreas Herrlich, Associate Professor of Medicine in the Division of Nephrology, is co-author […]